Studies of RANKL and OPG levels in patients with CKD and hemodialysis have shown contradictory results, with increased OPG levels and RANKL levels that can range from high to low when compared to healthy controls, requiring further studies [21,22]. This evidence concerns the gene TNFRSF11B and chronic kidney disease.